2025.09. 23 本文字数：2166，阅读时长大约4分钟 作者 | 第一财经 钱小岩 封图 | 张文宏在2025浦江创新论坛 （来源：浦江创新论坛提供） "我们不能把科学工作停留在论文上面，而是要让它落地，走向全球的各个角落。不仅要越过高山大 海，更要跨越科技与交流的鸿沟，最终打破全球健康不平衡，消除健康不平等"，国家传染病医学中 心（上海）主任、复旦大学附属华山医院感染科主任、上海感染与免疫科技创新中心主任张文宏如是 说。 他是9月22日在2025浦江创新论坛"未来健康：全球健康与发展论坛"（以下简称"论坛"）开幕致辞中 作出上述呼吁的。在论坛上，全球健康创新研究院宣布正式启动，这是中国首家以全球健康为使命的 新型研发转化机构。 全球健康创新研究院主要致力于推动面向中低收入国家需求的健康产品从实验室走向市场的转化阶 段。 盖茨基金会北京代表处副主任龚文峰向第一财经记者表示，这一阶段往往资金需求大、风险 高，因此当前无论是政府还是企业，都越来越重视对产品转化的投入与支持。 他进一步表示，全球健康创新研究院不仅仅注重推动产品开发，更重要的是发挥资源整合作用，它致 力于对接国内的原始研发和生产能力，并整合国 ...

全球健康创新研究院正式启动。 "我们不能把科学工作停留在论文上面，而是要让它落地，走向全球的各个角落。不仅要越过高山大 海，更要跨越科技与交流的鸿沟，最终打破全球健康不平衡，消除健康不平等"，国家传染病医学中心 （上海）主任、复旦大学附属华山医院感染科主任、上海感染与免疫科技创新中心主任张文宏如是说。 他是9月22日在2025浦江创新论坛"未来健康：全球健康与发展论坛"（以下简称"论坛"）开幕致辞中作 出上述呼吁的。在论坛上，全球健康创新研究院宣布正式启动，这是中国首家以全球健康为使命的新型 研发转化机构。 全球健康创新研究院主要致力于推动面向中低收入国家需求的健康产品从实验室走向市场的转化阶段。 盖茨基金会北京代表处副主任龚文峰向第一财经记者表示，这一阶段往往资金需求大、风险高，因此当 前无论是政府还是企业，都越来越重视对产品转化的投入与支持。 全球健康创新研究院首期五年研发经费由上海市和盖茨基金会共同提供，其中盖茨基金会提供项目赠款 和技术支持，上海市提供相应经费和资源。 转化落地 张文宏表示，全球仍面临结核病与疟疾等传染病的巨大挑战，当前核心任务在于推动科技创新成果真正 走向应用。 中国是结核病的高负担 ...

这是一款会烫米粉的机器人：它灵活地挥动双臂，煮粉、舀汤、配料、调味一气呵成。一连串动作 看似简单，实则每个环节都需要精确把控。在近日闭幕的2025世界机器人大会上，多款"绵阳造"机器人 及其核心部件产品受到业界关注。 这是一款新型磁钢产品：在保持性能基本不变的前提下，无需添加重稀土元素，即可降低成本15% —20%。不久前，绵阳巨星永磁材料有限公司发布的这款产品，代表着绵阳磁性材料产业实现最新突 破。 这些来自绵阳的新产品，正是当地聚焦科技资源的"我有"与产业发展的"我能"，一头抓好科技创新 成果转化"第一公里"，一头对接产业生态完善"最后一公里"，"双轮驱动"推动绵阳高质量发展的生动注 脚。 有技术、有人才，也有产业方向，资金难题如何破解？这个任务，落在同一栋大楼内的绵阳科技城 科技创新投资有限公司（简称科创投）肩上。 科技创新投资风险大、失败率高，当产业基金、风投基金看不懂时，自然不敢投。而科创投与天府 产业技术研究院的联动就是要破解这个难题——天府产业技术研究院负责遴选与转化，科创投则敢 于"投早投小"，从而实现技术转化与投资成功的"双提升"。"二者联动变身为优秀技术与先进产业的'称 重机'和'加速器' ...

会上，9位委员企业家代表结合实际，从加快科技创新成果转化、加大科技创新领域金融支持、鼓 励民间资本参与创投、加快人工智能赋能千行百业、夯实数字底座、打造韧性智慧城市、加强人才引 育、文化创意产业发展、现代农业产业发展、促进共同富裕等方面提出意见建议。市发改委相关负责人 作回应发言。 马卫光不时与企业家互动交流。他说，大家的发言立足实际、直面问题、恳切务实、建议中肯，为 相关部门科学编制"十五五"规划拓展了思路、提供了参考。他指出，"十五五"时期是杭州抢抓战略机 遇、塑造发展新动能新优势的关键五年，高质量编制"十五五"规划是今年全市上下一件大事。市政协认 真贯彻省市委部署要求，将围绕做好"十五五"规划编制开展协商议政作为重点履职任务，组织开展多个 层面调研，扎实推进协商准备工作。企业家处于经济活动一线，对市场趋势的感受更敏锐，对产业发展 和科技创新的把握更直接。希望大家结合企业发展积极建言献策，为编制"十五五"规划提出更多有价值 的"金点子"。要进一步弘扬企业家精神，紧跟国家重大发展战略步伐，切实发挥企业创新主体作用，在 各行各业持续引领创新、推动发展，把高质量规划绘就的蓝图转化为高质量发展的实景。市相关部门要 ...

Core Viewpoint - The third China International Supply Chain Promotion Expo, held from July 16 to 20, 2023, in Beijing, aimed to address challenges such as economic globalization backlash, rising trade protectionism, and increasing geopolitical conflicts, with participation from 651 enterprises and organizations from 75 countries and regions, emphasizing the importance of global supply chain cooperation [1][2]. Group 1: Event Overview - The expo attracted 651 enterprises and institutions, with 35% of exhibitors from overseas, an increase of 3 percentage points from the previous year, and a 15% growth in the number of participating U.S. companies [1]. - Over 65% of exhibitors were from the Fortune Global 500 and industry leaders, alongside numerous specialized and innovative "hidden champion" enterprises [1][2]. Group 2: China's Role in Global Supply Chains - China is recognized as a "stabilizing anchor" in global supply chains, with a complete industrial system and continuous technological innovation, providing high-quality manufacturing and creation to the world [2]. - The expo serves as a practical platform for promoting global supply chain cooperation, evolving from a display platform to a crucial hub for deep collaboration and sharing opportunities [2]. Group 3: Industry Collaboration and Innovation - The expo facilitated efficient connections among upstream, midstream, and downstream enterprises, with over 500 partners participating, and organized by industry chain themes such as advanced manufacturing, smart automotive, and digital technology [2][3]. - An innovation chain area was introduced to focus on intellectual property transformation, showcasing the entire process from basic research to market feedback, addressing challenges in technology application and resource allocation [3]. Group 4: Global Cooperation and Insights - The expo released the "Global Supply Chain Promotion Report" and introduced the global supply chain index matrix, including innovation and resilience indices for the first time, enhancing international collaboration and providing insights into supply chain trends [3]. - Participants utilized the expo as a platform for open dialogue and practical cooperation, aiming to enhance the resilience and security of global supply chains and contribute to economic recovery and prosperity [3].

Group 1 - The "Investment Chengdu" Global Investment Conference highlighted significant projects, including the signing of the "Star Calculation Plan" global headquarters and major funding for the aviation industry [1] - Chengdu Investment Group's investment of 1 billion yuan in the aviation engine company aims to enhance local industry capabilities and support the development of high-end aviation equipment [1] - The group has implemented over 60 major industrial projects, attracting a total investment of approximately 400 billion yuan, contributing to the modernization of the local industrial system [1][6] Group 2 - The electronic information industry is a key focus for Chengdu, with efforts to attract major companies in the semiconductor sector to address challenges in chip production [2] - Chengdu Investment Group has successfully established a Micro-LED production line, marking a significant advancement in next-generation display technology [2] - The group is actively involved in national funds to support major projects, with over 10 billion yuan expected to be reinvested in Chengdu [2] Group 3 - The equipment manufacturing sector is crucial for the economy, with Chengdu Investment Group supporting local companies in the aerospace industry and promoting the development of high-end power equipment [3] - A new manufacturing center for turbine and engine core equipment is under construction, expected to produce 100 units annually and generate over 5 billion yuan in annual output [3] Group 4 - Chengdu Investment Group is driving the green transformation of industries, focusing on lithium battery production and clean energy initiatives [5] - The group has attracted leading companies in the battery sector and is investing in hydrogen energy projects to support the development of a world-class lithium battery industry [5] Group 5 - Chengdu Investment Group has invested in various innovative projects in the low-altitude and commercial space sectors, enhancing the city's competitiveness in these emerging industries [5] - The successful launch of the world's first space computing constellation by Guoxing Aerospace signifies Chengdu's advancements in commercial space [4][5] Group 6 - The group is focused on nurturing long-term capital and has plans to establish a third phase of its industrial fund to support major industrial projects [6] - Chengdu Investment Group aims to optimize the local industrial system, promoting collaboration across various sectors and enhancing the overall economic landscape [6]

Core Insights - The "Innovation and Entrepreneurship Investment Conference" in Shenzhen showcased the integration of technology innovation and capital, emphasizing the importance of collaboration among various stakeholders [1][4][6] - Since its inception in 2020, the conference has collected 24,864 quality projects across strategic emerging industries such as AI, biomedicine, and new energy vehicles [1] - The current conference focused on five cutting-edge sectors: new generation information technology, high-end equipment manufacturing, green low-carbon & new materials, biomedicine, and digital economy, featuring over 50 innovative results [1][4] Event Highlights - The conference featured immersive roadshows for benchmark projects in the five sectors, allowing for a comprehensive display of advanced technologies [4] - Representatives from various districts in Shenzhen promoted their regional industrial positioning and policy advantages, enhancing local collaboration [4] - The event also recognized the top 10 industry projects and outstanding organizations for their contributions to technological innovation [4] Future Plans - The conference announced a work plan for 2025, aiming to collect 500 quality projects with at least 70% from outside the city, focusing on grassroots empowerment and city-district collaboration [8] - The plan includes a customized "one district, one industry map" to better align technical demands with project resources [8] Support Mechanisms - The conference facilitated one-on-one discussions between outstanding project teams and quality investment institutions, addressing financing challenges for technology workers [6] - The Shenzhen Association for Science and Technology and other local organizations are committed to providing comprehensive support throughout the project lifecycle [10]

Core Viewpoint - In 2024, Yiling Pharmaceutical (002603) faced competitive pressure in the pharmaceutical industry and adhered to a strategy focused on "standardization, professionalism, health, sustainability, and leapfrogging," aiming for brand success, scale formation, goal achievement, and profit creation [1] Financial Performance - In 2024, Yiling Pharmaceutical reported revenue of 6.513 billion yuan, a year-on-year decrease of 36.88%, and a net profit attributable to shareholders of -0.725 billion yuan, down 153.57% [2] - The decline in performance was attributed to the expiration of certain respiratory products, leading to reduced sales and inventory impairment losses, alongside rising raw material costs and sustained high R&D investments [2] - Despite the net loss, operating cash flow significantly improved, reaching 0.611 billion yuan, a year-on-year increase of 293%, with Q4 cash flow alone at 0.288 billion yuan, up over 26 times [2] - Accounts receivable decreased significantly, with a reduction of 1.176 billion yuan, a drop of 50%, and total liabilities decreased to 3.117 billion yuan, down 24.24 billion yuan or 43.75%, resulting in a debt-to-asset ratio decline of nearly 10 percentage points to 23.4% [2] R&D Investment - Yiling Pharmaceutical maintained a strong focus on R&D, with expenses reaching 0.908 billion yuan in 2024, accounting for 13.94% of revenue, reinforcing its leadership in traditional Chinese medicine innovation [3] - The company developed 17 innovative traditional Chinese medicines targeting eight major clinical disease systems, achieving industry leadership in cardiovascular and respiratory disease treatments [3] - New drug approvals included a treatment for allergic rhinitis and a new drug for gallbladder inflammation, with several patented traditional medicines included in the new medical insurance directory [3] Market Expansion and Strategic Initiatives - Yiling Pharmaceutical has registered products in over 50 countries and regions, actively entering the biopharmaceutical and health sectors, with recent approval for a breast cancer treatment [4] - Continuous R&D investment is expected to enhance product offerings and market share, while the transformation of technological innovations will improve product structure and competitiveness [4] - The company’s strategic focus on R&D and market trends positions it for greater growth in the pharmaceutical market [4] 2025 Outlook - In Q1 2025, Yiling Pharmaceutical reported revenue of 2.358 billion yuan and a net profit of 0.326 billion yuan, reflecting a year-on-year increase of 7.25% [5] - The company’s operating cash flow reached 0.34 billion yuan, nearly doubling year-on-year, with gross margin increasing by 2.34 percentage points to 53.82% [5] - The company aims to enhance its innovation capabilities, accelerate drug development, and implement a brand strategy while optimizing operational management and cost control [6]

Group 1 - The third China (Anhui) Science and Technology Innovation Achievement Transformation Fair was held from April 26 to 28, focusing on "Technology Leading, Innovation Winning the Future" [1] - A total of 378 exhibitors showcased 1,204 exhibits, with 28% being first-time launches and 18% being internationally leading products [2] - The event highlighted significant technological advancements, including the world's first data-driven automated chemist platform and the first domestic cold field scanning electron microscope [2][3] Group 2 - The fair featured the global debut of the "Mighty Lion Third Generation Flying Car" from Tsinghua University, designed for urban air mobility [4] - The Long Triangle National Technology Innovation Center presented over 50 exhibits, aiming to facilitate the implementation of innovative results in Anhui and promote local innovations globally [4] - The fair successfully matched 400 projects with a total investment exceeding 100 billion yuan, showcasing Anhui's commitment to becoming a significant hub for technological innovation [6]

Core Viewpoint - The third China (Anhui) Science and Technology Innovation Achievements Transformation Fair opened in Hefei, Anhui Province, focusing on the theme "Technology Leads, Innovation Wins the Future" [1][4][8]. Group 1: Event Overview - The fair attracted over 2,000 enterprises and nearly 200 universities and research institutions from both domestic and international sectors [1][4][8]. - The total exhibition area is 20,000 square meters, featuring six display and docking areas: Hall of Order, Technology Leadership, Industrial Innovation, Ecological Empowerment, "Double Recruitment and Double Introduction" roadshow docking, and new technology and product experience [1][4][8]. - Ten specialized docking activities will be held, including project roadshows and transactions to promote the implementation of technology projects [1][4][8]. Group 2: Exhibits and Activities - The fair showcased the latest technological achievements from both domestic and international sources [1][4][8]. - Attendees experienced various innovative products, including VR devices, robotic pianos, flying cars, and AI transparent screens [3][11][19][21][23].